MAPK8 and ischemia: Previous research has shown that a dual NO‐donating oxime and JNK inhibitor is reported to safeguard cells against cerebral ischemia‐reperfusion injury, indicating JNK inhibitor use is accessible for investigation on functions of JNK in ischemia injury (Atochin et al., 2016).